Next-generation novasure ® device for endometrial ablation: Assessing ease-of-use among physicians

Abstract

Objective: To compare physician assessment of the next-generation NovaSure ® device to the original NovaSure device. Design: Prospective open-label, unblinded survey utilizing Likert scales. Setting: Community-based obstetrician and gynecology practices. Patients: There were 270 evaluations completed by 168 physicians for women undergoing endometrial ablation with the next-generation NovaSure device compared to the previous model. Interventions: Physician survey across multiple community-based obstetrician and gynecology practices. Measurements and main results: In general, 53.7% of women had a normal uterus, with an average cavity length of 5.3 cm ± 0.9 cm, and 44.7% of women had a normal cervix. Overall, 98.7% of physicians agreed or strongly agreed that they were satisfied with the performance of the next-generation NovaSure device compared with the previous device. Additionally, 89% of physicians rated the next-generation NovaSure device as superior to the previous device. The best rated features were the SureFit TM Cervical Seal, Smooth Access TM Tips, and the thumbpusher. No adverse events were reported in this study. Conclusion: Community-based physicians rated the next-generation NovaSure device as superior to the previous model in a general population of women. © 2012 Pollock and Jamieson, publisher and licensee Dove Medical Press Ltd.